||5R50CA211115-04 Interpret this number
||Kaiser Foundation Research Institute
||Group Health Cancer Research Program Research Specialist Award
The goal of this application is to support Erin Bowles, MPH, as a Senior Research Associate at Group Health
Research Institute. She supports the Cancer Research Group on multiple NCI-funded projects under the
direction of Diana Buist, PhD. Ms. Bowles is an accomplished epidemiologic cancer scientist in areas such as
breast cancer screening and treatment. Her work is primarily funded by the National Cancer Institute. Group
Health is a learning healthcare system, giving her work the potential to be translated and disseminated into
clinical practice. This Research Specialist Award would provide her with 5 years of funding during which she
would commit to working on NCI-funded projects such as the Breast Cancer Surveillance Consortium and
Cancer Research Network. These projects have had measurable impacts on healthcare and health outcomes
in the US, such as contributing to national breast cancer screening guideline development and providing
population-based estimates of cancer treatment outcomes beyond results from clinical trials. On these
projects, Ms. Bowles will fill various roles including site PI, project/data manager, clinical liaison,
mammographic density reader, statistical analyst, grant writer, publication author, and cancer epidemiologist.
She will actively work to ensure project results are broadly disseminated to clinical practice.
Risk of colon cancer recurrence in relation to diabetes.
, Yu O.
, Ziebell R.A.
, Bowles E.J.A.
, Sterrett A.T.
, Fujii M.M.
, Boggs J.M.
, Burnett-Hartman A.N.
, Boudreau D.M.
, Chen L.
, et al.
Cancer Causes & Control : Ccc, 2018-09-22 00:00:00.0; , .
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
, Cuzick J.
, Buist D.S.M.
, Bowles E.J.A.
Jama Oncology, 2018-09-01 00:00:00.0; 4(9), p. e180174.
Physician Perspectives On Increasing Minorities In Cancer Clinical Trials: An Eastern Cooperative Oncology Group (ecog) Initiative
, McCaskill-Stevens W.
, Wolfe P.
, Marcus A.C.
Annals Of Epidemiology, 2000 Nov; 10(8 Suppl), p. S78-84.
High-dose Cytosine Arabinoside And M-amsa Is Effective Therapy In Relapsed Acute Nonlymphocytic Leukemia
, Oken M.M.
, Mazza J.J.
, Keller A.M.
, Streeter R.R.
, Glick J.H.
Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 1984 Jun; 2(6), p. 545-9.